Demyelination as An Epiphenomenon in Multiple Sclerosis

References

• Adams R. D., Victor M. Principles of neurology. 3rd Edition. McGraw-Hill Book Company., New York 1985; 699–717
   Google Scholar
• Aita J. F., Bennct D. R., Anderson R. E. Cranial CT appearance of acute multiple sclerosis. Neurology 1978; 28: 251–255
   PubMed Web of Science ®Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Berger J., Sheremata W. Persistent neurological deficit precipitated by hot bath test in MS. Journal of the American Medical Association 1983; 249: 1751–1753
   PubMed Web of Science ®Google Scholar
• Bhargava V. K., McKean C. M. Role of 5-hydroxytryptamine in the modulation of acoustic brainstem (far-field) potentials. Neuropharmacology 1977; 16: 447–449
   PubMed Web of Science ®Google Scholar
• Bornstein M. B. Textbook of immunopathology: central nervous system. Grune & Stratton Inc., New York 1968; 507–515
   Google Scholar
• Broman T. Blood brain barrier damage in multiple sclerosis: supra-vital test observations. Acta Neurologica Scandinavica 1964; 40: 21–24, Suppl 10
   PubMed Web of Science ®Google Scholar
• Carnegie P. R. Relationship of methylarginine to the main encephalitogenie determinant and some speculative implications for multiple sclerosis. Multiple sclerosis progress in research, E. J. Field, T. M. Bell, P. R. Carnegie. North Holland Publishing., Amsterdam 1972; 63–69
   Google Scholar
• Chiappa K. H., Harrison J. L., Brooks E. B., Young R. R. Brainstem auditory evoked responses in 200 patients with multiple sclerosis. Annals of Neurology 1980; 7: 135–143
   PubMed Web of Science ®Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology. Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgergy, and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Davis F. A. Pathophysiology of multiple sclerosis and related clinical implications. Modern Treatment 1970; 7: 890–902
   PubMedGoogle Scholar
• Fredrikson S., Link H., Eneroth P. CSF neopterin as marker of disease activity in multiple sclerosis. Acta Neurologica Scandinavica 1987; 75: 352–355
   PubMed Web of Science ®Google Scholar
• Gawel M. J., Das P., Vincent S. Visual and auditory evoked responses in Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Kent Pitman Medical. 1981; 138–146
   Google Scholar
• Georgi W. Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochenschrift. 1961; 91: 605–607
   PubMedGoogle Scholar
• Ghatak N. R., Hirano A., Lijtmaer H., Zimmerman H. M. Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology 1974; 30: 484–486
   PubMedGoogle Scholar
• Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Archives of Neurology 1983; 40: 533–536
   PubMedGoogle Scholar
• Halliday A. M. Clinical applications of evoked potentials. Recent advances in clinical neurology, W. B. Matthews, G. H. Glaser. Churchill Livingstone., Edinburgh 1978; 47–73
   Google Scholar
• Balliday A. M., Wakefield G. W. Cerebral evoked potentials in patients with dissociated sensory loss. Journal of Neurology, Neurosurgery and Psychiatry 1963; 26: 211–219
   PubMedGoogle Scholar
• Halliday A. M., McDonald W. I. Pathophysiology of demyelinating disease. British Medical Bulletin 1977; 33: 21–27
   PubMed Web of Science ®Google Scholar
• Harrer G., Fischbach R. Uber die wirkung bestimmter aminosauren auf das ergebniss des unberwarmungstests bein multiple sclerose kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Holder G. E., Bartlett J. R., Bridges P. K., Kantamanei B. D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Hughes R. A. C. Prospects for the treatment of multiple sclerosis. Journal of the Royal Society of Medicine 1991; 84: 63–65
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jacobs L., Kinkel P. R., Kinkel W. R. Silent brain lesions in patients with isolated optic neuritis. Archives of Neurology. 1986; 43: 452–455
   PubMedGoogle Scholar
• Johansson B., Ross B. E. 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology. II 1977; 37–45
   Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Koella W. P., Czicman J. S. Influence of serotonin upon optic evoked potentials, EEG, and blood pressure of cat. American Journal of Physiology 1963; 204: 873–880
   PubMedGoogle Scholar
• Koopmans R. A., Li D. K. B., Oger J. J. F., Mayo J., Paty D. W. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Koya G., Suzuki M., Baba M., Iwabuchi T. An autopsy case of concurrence of multiple sclerosis and glioma. Hirosaki Medical Journal 1977; 29: 588–596
   Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Li D. K. B., Mayo J., Fache S., Robertson W., Lastrukoff L. F., Oger J., Paty D. W. Lack of correlation between clinical manifestations and lesions of MS as seen by NMR. Neurology 1984; 34: 136, suppl
   PubMed Web of Science ®Google Scholar
• Lynch S. G., Rose J. W., Smoker W., Petajan J. H. MRI in familial multiple sclerosis. Neurology 1990; 40: 900–903
   PubMed Web of Science ®Google Scholar
• MackKay R. P., Hirano A. Forms of benign multiple sclerosis: report of two clinically silent cases discovered at autopsy. Archives of Neurology 1967; 17: 588–600
   PubMedGoogle Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• McDonald W. I. Pathophysiology of conduction in central nerve fibres. Visual evoked potentials in man: new developments, J. Desmedt. Claredon Press., Oxford 1977; 423–437
   Google Scholar
• McDonald W. I., Barnes D. Lesson from magnetic resonance imaging in multiple sclerosis. Trends in Neuroscience 1989; 12: 376–379
   PubMed Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Morariu M., Klutzow W. F. Subclinical multiple sclerosis. Journal of Neurology 1976; 213: 71–76
   PubMed Web of Science ®Google Scholar
• Namerow N. S., Thompson L. B. Plaques, symptoms, and the remitting course of multiple sclerosis. Neurology 1969; 19: 765–774
   PubMedGoogle Scholar
• Onofrj M., Bazzano S., Malatesta G., Gambi D. Pathophysiology of delayed evoked potentials in multiple sclerosis. Functional Neurology 1990; 5: 301–319
   PubMedGoogle Scholar
• Ormerod I. E. C., Du Boulay G. H., McDonald W. I. Imaging of multiple sclerosis. Multiple sclerosis, W. I. McDonald, D. H. Silberg. Butterworths., London 1986; 11–36
   Google Scholar
• Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 414–420
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Quarles R. H., Shin M. L., Waksman B. H. A workshop on mechanisms of myelin breakdown. Annals of Neurology 1986; 19: 97
   PubMedGoogle Scholar
• Rao N. A. Chronic experimental allergic optic neuritis. Investigative Ophthalmology and Visual Sciences 1981; 20: 159–172
   PubMed Web of Science ®Google Scholar
• Robinson K., Rudge P. Auditory evoked responses in multiple sclerosis. Lancet 1975; I: 1164–1166
   Google Scholar
• Robinson K., Rudge P. Abnormalities of the auditory evoked potentials in patients with multiple sclerosis. Brain 1977; 100: 19–40
   PubMed Web of Science ®Google Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Russel D. S. Trauma and multiple sclerosis. Lancet 1964; 1: 978
   Google Scholar
• Sandyk R. The pineal gland and multiple sclerosis. (Editorial). International Journal of Neuroscience 1992a; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992b; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience, (in press a)
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience, (in press b)
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Multiple sclerosis: the role of the pineal gland in its timing of onset and risk of psychiatric illness. International Journal of Neuroscience, (in press c)
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Pineal calcification and its relationship to the fatigue of multiple sclerosis. International Journal of Neuroscience, (in press d)
   Google Scholar
• Sandyk R., Awerbuch G. I. Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. International Journal of Neuroscience, (in press e)
   Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience, (in press a)
   Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience, (in press b)
   Google Scholar
• Sandyk R., Iacono R. P. Improvement of visuoperceptive functions in multiple sclerosis by picoTesla range magnetic fields. International Journal of Neuroscience, in press
   Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser., Boston 1992; 53–62
   Google Scholar
• Sharma H. S., Dey P. K. Influence of long term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Journal of Neurological Sciences 1986a; 72: 61–76
   PubMed Web of Science ®Google Scholar
• Sharma H. S., Dey P. K. Probable involvement of 5-hydroxytryptamine in increased permeability of blood brain barrier under heat stress in young rats. Neuropharmacology 1986b; 25: 161–167
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Vost A., Wolochow D. A., Howell D. A. Incidence of infarcts of the brain in hear disease. Journal of Pathology & Bacteriology 1964; 88: 463–470
   PubMedGoogle Scholar
• Vuia O. The benign form of multiple sclerosis anatomo-clinical aspects. Acta Neurologica Scandinavica 1977; 55: 289–293
   PubMed Web of Science ®Google Scholar
• Waxman S. G. Clinical course and electrophysiology of multiple sclerosis. Advances in neurology. Functional recovery in neurological disease, S. G. Waxnian. Raven Press, New York 1988; vol. 47: 157–184
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Werner E. R., Bitterlich G., Fuchs D. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sciences 1987; 41: 274–280
   Google Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis. An experimental model of multiple sclerosis. Annals of Neurology 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Young I. R., Hall A. S., Pallis C. A. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063–1066
   PubMed Web of Science ®Google Scholar